Added to YB: 2025-09-18
Pitch date: 2025-09-16
VIRP.PA [neutral]
Virbac SA
+10.05%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.
Market Cap
EUR 2.7B
Pitch Price
EUR 313.50
Price Target
N/A
Dividend
0.46%
EV/EBITDA
10.32
P/E
20.00
EV/Sales
1.99
Sector
Pharmaceuticals
Category
value
Virbac (VIR France): Soft first half but confidence in rebound
VIRP.PA (quick overview): H1 operating profit -10%, margins down 3pts due to one-offs (inventory write-offs, opex timing, maintenance downtime). Guidance unchanged: 4-6% sales growth, ~16% EBIT margins, H2 FCF rebound. Trades at discount to peers despite strong positioning in companion animals/emerging mkts.
Read full article (1 min)